Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ESCITALOPRAM OXALATE

ESCITALOPRAM OXALATE

Standard Dose
EQ 5MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ESCITALOPRAM OXALATE is listed in Drugs@FDA under application 203967 (ANDA).

Marketing status: Discontinued Active ingredient ESCITALOPRAM OXALATE Form and strength SOLUTION;ORAL - EQ 5MG BASE/5ML Sponsor ANTRIM PHARMS LLC Submission history Latest submission status date: 2015-05-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview ESCITALOPRAM OXALATE is listed in Drugs@FDA under application 203967 (ANDA). Marketing status: Discontinued Active ingredient ESCITALOPRAM OXALATE Form and strength SOLUTION;ORAL - EQ 5MG BASE/5ML Sponsor ANTRIM PHARMS LLC Submission history Latest submission status date: 2015-05-26 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.